AgomAb Therapeutics NV American Depositary Shares
Market Cap
620M
Short interest (Jul 15)
2.5%
Net Short (Jul 27 ): 0.0%
Borrow Fee
12.47%
↓ 3.8%
Available Shares
300K
↑ 15.6%
Price Chart
Company Overview
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.